Cecilia Jones, Chief Financial Officer at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 4,358 shares at $24.79 ($108K) on 2023-09-28, disclosed to the SEC on 2023-09-28.
Scheduled sale ($108k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.79 | 2,179 | $54K | 50.0% |
| 2 | $24.79 | 2,179 | $54K | 50.0% |
| Total | $24.79 avg | 4,358 | $108K | 100% |
| Filing → |
| AGIO | SELL | 2026-01-02 | $79K | — | Filing → |
| AGIO | SELL | 2025-09-30 | $268K | — | Filing → |
| AGIO | SELL | 2025-06-26 | $119K | — | Filing → |